Malta vs Seychelles: Tuberculosis patients living with HIV receiving antiretroviral therapy
Malta
1 patients
in 2021
Seychelles
1 patients
in 2021
Malta rank
130th
Seychelles rank
130th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Malta
- Seychelles
How they compare
Malta currently reports 1 patients against 1 patients in Seychelles, a difference of 0 patients.
The two have swapped places 3 times across 9 shared years of data; in 2003 it was Malta ahead.
Malta ranks 130th and Seychelles ranks 130th of 183 countries.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malta | Seychelles | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2 patients | 0.6667 patients | 1.33 patients | Malta |
| 2010s | 3 patients | 0.75 patients | 2.25 patients | Malta |
| 2020s | 1.5 patients | 1.5 patients | 0 patients | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Malta or Seychelles?
- Malta, at 1 patients against 1 patients in Seychelles as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Malta and Seychelles?
- 0 patients, with Malta ahead.
- How many years of comparable data are there for Malta and Seychelles?
- 9 years are reported by both, from 2003 to 2021.
- How do Malta and Seychelles rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Malta ranks 130th and Seychelles ranks 130th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.